Medindia

X

DSM Biologics to Acquire Rhobust(TM) Technology from Upfront Chromatography A/S

Tuesday, May 4, 2010 General News J E 4
Advertisement

For more information:

Rolf Douwenga

Spencer Reynolds

Vice President, Research and Development

Director, New Business Development

DSM Biologics

DSM Biologics

Tel: +1-973-257-8220

Tel: +1-973-257-8056

Rolf.Douwenga@dsm.com

Spencer.Reynolds@dsm.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Palisade Systems Delivers Next Generation Data Los...
S
Nick Jonas and Bayer Diabetes Care Announce 'Give ...